Search Results 2601-2610 of 17356 for Green Birth Control

1. Fecal Microbiota Transplantation For C. Difficile Infection In Solid Organ Transplant Recipients - Mayo Clinic

   diff infection (CDI) in solid organ transplant (SOT) recipients in a randomized, controlled clinical trial. Participation eligibility. Participant ...

2. Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids - Mayo Clinic

   an intra-duodenal Intralipid infusion (both compared to saline control). We will compare the muscle FFA storage into intramyocellular triglyceride ...

3. A Study to Evaluate COVID Brain Advanced Imaging Network - Mayo Clinic

   Individuals who had no known COVID-19 exposure (for controls) or had PCR or antibody confirmed COVID-19 who present with neurological symptoms in the months ...

4. A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma

   About this study. A prospective, randomized, double-masked, dosing-frequency-controlled, multicenter clinical trial evaluating the safety and activity of ...

5. A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol - Mayo Clinic

   ... management/treatment; and patients receive genetic testing as described above. Self-identified as being from various ethnic populations including Hispanic ...

6. A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection - Mayo Clinic

   This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low anterior resection ...

7. The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

   About this study. This is a global, multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study ...

8. A Trial To Evaluate The Efficacy And Safety Of Ninerafaxstat In Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy - Mayo Clinic

   About this study. FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and ...

9. Clinical Trials - ALN-TTR02-012

   This includes significant active and poorly controlled (unstable) cardiovascular disorders and untreated hypo- or hyperthyroidism. Known primary amyloidosis ...

10. A Multi-Center Observational Trial Of Symptomatic High-Risk Bone Metastases Treated With Percutaneous Ablation And Palliative Radiation Therapy - Mayo Clinic

    Skeletal metastasis with localized pain not controlled medically \[recall within last 24 hours of worst pain ≥ 5 using the BPI\] * 2. Pain must be from one ...